Tumor Biology

, Volume 32, Issue 2, pp 391–397 | Cite as

A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor

  • Heiying Jin
  • Zhijian Yang
  • Jiangdong Wang
  • Suying Zhang
  • Yu Sun
  • Yijiang Ding
Research Article

Abstract

The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 cells were transduced with a pLPCX expression retroviral vector containing green fluorescent protein and neomycin resistance genes. For superficial orthotopic transplantation model, the cecum was identified and pulled out of the peritoneal cavity, the space between the cecum and peritoneum was sutured, the cecum was pulled to subcutaneous tissue, and incision was made on the cecal serosa followed by the implantation of a 1-mm tumor tissue to the cecum. For comparison, a conventional orthotopic transplantation model was established in a separate group of mice simultaneously. When tumor sizes reached 5 mm in diameter, half the mice in each model received 5-FU treatment. Primary tumor and metastases were monitored by fluorescent imaging or caliber measurement. Tumor fluorescence was observed as early as 3 days (median time of 4.7 ± 1.3 days) post-transplantation in the superficial orthotopic transplantation model, which was much earlier than 21 days (median time of 26.2 ± 9.9 days) in conventional orthotopic transplantation model. Although tumor growth of 5-FU-treated mice in conventional orthotopic model was lower than those of the untreated mice, the difference was not significant. However, in superficial orthotopic model, tumor growth was significantly inhibited in 5-FU-treated mice relative to the untreated mice. Fluorescence imaging showed similar metastasis incidence between the superficial and conventional orthotopic transplantation models. The fluorescent superficial orthotopic transplantation colon model allows easier real-time visualization and more sensitive monitoring of tumor growth as well as convenient repeated sampling. It is a valuable orthotopic implantation model for study of colon cancer and evaluation of new anti-cancer therapy.

Keyword

Colorectal cancer Orthotopic transplantation colon model Fluorescent imaging 

Notes

Competing interests

There are no competing interests (political, personal, religious, academic, ideological, intellectual, commercial, or any other) to declare in relation to this manuscript.

References

  1. 1.
    Taketo MM. Mouse models of gastrointestinal tumors. Cancer Sci. 2006;97(5):355–61.CrossRefPubMedGoogle Scholar
  2. 2.
    Rho YS, Lee KT, Jung JC, Yoon C, An Z, Hoffman RM, et al. Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer. Anticancer Res. 1999;19:157–62.PubMedGoogle Scholar
  3. 3.
    Ji Y, Hayashi K, Amoh Y, Tsuji K, Yamauchi K, Yamamoto N, et al. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer. Anticancer Res. 2007;27:713–8.PubMedGoogle Scholar
  4. 4.
    Hoffman RM. Orthotopic is orthodox. Why are orthotopic-transplant metastatic models different from all other models? J Cell Biochem. 1994;56:1–3.CrossRefPubMedGoogle Scholar
  5. 5.
    Rashidi B, Sun FX, Jiang P, An Z, Gamagami R, Moossa AR, et al. A nude mouse model of massive liver and lymph node metastasis of human colon cancer. Anticancer Res. 2000;20:715–22.PubMedGoogle Scholar
  6. 6.
    Hoffman RM. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Meth Mol Med. 2005;111:297–322.Google Scholar
  7. 7.
    Hoffman RM. Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis Rev. 1998–1999;17:271–7.CrossRefGoogle Scholar
  8. 8.
    Marchal F, Tran N, Marchal S, Leroux A, Marchal C, Bolotine L, et al. Development of an HT29 liver metastases model in nude rats. Oncol Rep. 2005;14:1203–7.PubMedGoogle Scholar
  9. 9.
    Jin H, Liu X, Li VK, Ding Y, Yun S, Liu F, et al. A simple colostomy implantation model for evaluating colon cancer. Int J Colorectal Dis. 2009;24:41–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H, et al. Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res. 2006;66:4208–14.CrossRefPubMedGoogle Scholar
  11. 11.
    Hoffman RM, Yang M. Whole-body imaging with fluorescent proteins. Nat Protoc. 2006;1:1429–38.CrossRefPubMedGoogle Scholar
  12. 12.
    Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer. 2005;5:796–806.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2010

Authors and Affiliations

  • Heiying Jin
    • 1
  • Zhijian Yang
    • 2
  • Jiangdong Wang
    • 3
  • Suying Zhang
    • 2
  • Yu Sun
    • 2
  • Yijiang Ding
    • 1
  1. 1.National Center of Colorectal SurgeryThe 3rd Affiliated Hospital of Nanjing University of Traditional Chinese MedicineNanjingPeople’s Republic of China
  2. 2.Origin Biosciences Inc.NanjingPeople’s Republic of China
  3. 3.Department of PathologyNanjing General Hospital of PLANanjingPeople’s Republic of China

Personalised recommendations